Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Sees Large Decline in Short Interest

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) was the target of a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 1,909,300 shares, a decrease of 21.6% from the March 15th total of 2,434,400 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Genomma Lab Internacional Stock Performance

Shares of Genomma Lab Internacional stock remained flat at $1.43 during trading on Monday. Genomma Lab Internacional has a 1-year low of $0.79 and a 1-year high of $1.43. The business has a 50-day moving average of $1.43 and a 200-day moving average of $1.31.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.